INDACATEROL / GLYCOPYRRONIUM INHALER (Ultibro Breezhaler®)
Clinical Indication
COPD
Comments
Reviewed by LLR Respiratory Prescribing Group, deemed not appropriate for review by TAS
Date of classification
February 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.